SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-21-003706
Filing Date
2021-02-12
Accepted
2021-02-12 17:20:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 170984
  Complete submission text file 0001493152-21-003706.txt   172734
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60943 | Film No.: 21629759
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108
Business Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108 617-904-9195
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

IRS No.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A